News

Cathie Wood's Latest Moves: Key Stock Sales and Purchases

Cathie Wood's Latest Moves: Key Stock Sales and Purchases

Recent Adjustments by Ark Invest

Cathie Wood's Ark Invest has been making noteworthy trades recently. The firm executed significant sales and purchases, reflecting its evolving strategy in a changing market environment. One of the major moves was the substantial sale of Tesla stock, a decision that has garnered a lot of attention amid ongoing conversations about profitability and the future of electric vehicles.

The Tesla Trade Explained

Ark Invest made headlines by selling shares of Tesla Inc. (NASDAQ: TSLA) across several exchange-traded funds, notably the ARK Innovation ETF (BATS: ARKK), ARK Autonomous Technology & Robotics ETF (BATS: ARKQ), and ARK Next Generation Internet ETF (BATS: ARKW). The total shares sold amounted to 60,715, translating to an estimated transaction value of around $29.7 million, based on Tesla's closing stock price of $488.73.

While many analysts express doubts about Tesla's profitability, with some highlighting potential challenges in achieving GAAP profitability soon, the company's market presence in the electric vehicle sector continues to be strong. This reflects a broader discussion about the sustainability of profit in the tech-driven automotive world.

Palantir's Adjusted Position

In another strategic move, Ark Invest reduced its stake in Palantir Technologies Inc. (NASDAQ: PLTR) by selling 47,309 shares through ARKQ and ARKW. This sale occurred when Palantir's stock price was around $193.98, equating to an approximate total of $9.2 million. However, optimism remains within the investment community regarding Palantir's growth potential, particularly as AI adoption surges and the company strengthens its U.S. commercial business.

Shifts in Shopify Holdings

Additionally, Ark Invest decided to sell 33,164 shares of Shopify Inc. (NASDAQ: SHOP) through the ARK Blockchain & Fintech Innovation ETF (BATS: ARKF) and ARKW. This trade was valued at around $5.6 million, given Shopify's closing price of $169.67. The e-commerce giant had recently introduced its Winter 2026 Edition, featuring enhanced capabilities, including AI integrations designed to foster growth among its merchant base.

WeRide's Acquisition in Robotaxi Market

On the investment front, Ark also made a notable move by purchasing 520,697 shares of WeRide Inc. (NASDAQ: WRD). Closing at $8.97, this acquisition was valued at approximately $4.7 million. WeRide has recently launched public Robotaxi services in Dubai, aspiring for a fully autonomous transit model by 2026. This move not only marks a significant milestone for the company but also aligns with global trends towards autonomous transportation.

Other Noteworthy Trades by Ark Invest

  • CRISPR Therapeutics AG (CRSP): Purchased 78,793 shares across ARKG and ARKK.
  • Intellia Therapeutics Inc. (NTLA): Acquired 187,880 shares via ARKG and ARKK.
  • Rocket Lab Corp. (RKLB): Sold 232,425 shares through ARKQ and ARKX.
  • Pacific Biosciences of California Inc. (PACB): Purchased 798,771 shares across ARKG and ARKK.
  • Twist Bioscience Corp. (TWST): Bought 24,488 shares through ARKG and ARKK.

These various trades indicate how Ark Invest is adapting to changes and challenges within the market. With a commitment to innovative solutions and a focus on technological advances, the fund continues to navigate through strategic decisions that impact its portfolio heavily.

Frequently Asked Questions

1. Why did Ark Invest sell Tesla stock?

Ark Invest sold Tesla stock as part of a strategic adjustment in response to market dynamics and concerns over the company's profitability.

2. What was the value of the shares sold in Palantir?

Ark Invest sold approximately $9.2 million worth of Palantir shares, reflecting a strategic move to adjust their position in the stock.

3. How is WeRide’s market entering?

WeRide recently launched public Robotaxi rides in Dubai, aiming for a fully driverless service by early 2026, which aligns with the growing push for autonomous vehicles.

4. What is the significance of Ark's holdings in Shopify?

Ark's investment in Shopify reflects confidence in the company's innovative direction and expansion into AI-driven solutions for better merchant support.

5. What other companies is Ark Invest currently involved with?

Ark Invest has significant holdings in companies like CRISPR Therapeutics, Intellia Therapeutics, Rocket Lab, and Pacific Biosciences, showcasing a diverse portfolio focused on innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 53

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 46

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 133

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Northern Virginia's Housing Inventory Surges Despite Market Pressures

Updated Category News Views 96

Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 134

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Monterey Desalination Project: Costs, Challenges & Future

Updated Category News Views 19

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...

Continue Reading
Empire Steak House Expands to Delray Beach

Updated Category News Views 57

Steakhouse Kings Bring New York Flavors to Florida When you're talking about steak, the Empire Steak House name carries some serious heft. This isn't just another restaurant chain cashing in on prime cuts; it's a family legacy over 21 years in the making. The Sinanaj Brothers, who honed their skills at Peter Luger in New York, are moving their empire south, landing a...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 31

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Callender Bowlin's Legal Eagles Soar in Texas 2026

Updated Category News Views 4

The Spotlight on CB Trial's Legal Titans Roll the dice, folks—who stands up in Texas’ legal playground? It's Callender Bowlin, PLLC's hotshots again securing their hallmark in the 2026 Texas Super Lawyers gauntlet. This ain’t their first rodeo, either. Founding partners Mark Callender and Josh Bowlin—names synonymous with high-stakes litigation—continue to bask...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 16

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Show Strong Interest in Micron Technology's Future

Updated Category News Views 116

Investor Interest in Micron Technology Investors looking for promising opportunities are increasingly focused on Micron Technology. This semiconductor giant has caught the attention of many, especially with its substantial trading activity. Understanding the Current Options Activity Recent data has revealed notable trades in Micron Technology's options. The presence of...

Continue Reading
Dundee Precious Metals Confirms Dividend Declaration for Shareholders

Updated Category News Views 144

Dundee Precious Metals Confirms Dividend Announcement Dundee Precious Metals Inc. (TSX: DPM) has announced a significant update regarding its financial strategy. The Board of Directors has formally declared a third-quarter dividend amounting to US$0.04 per common share. This decision reflects the company's ongoing commitment to providing value to its shareholders while...

Continue Reading
Praesidian Capital Celebrates Successful E-commerce Exit Strategy

Updated Category News Views 127

Praesidian Capital Celebrates Successful E-commerce Exit Strategy Recently, Praesidian Capital, a private equity firm, made headlines with its successful exit from a tech-enabled e-commerce consumer products distribution business. This move showcases the firm's strategic prowess in identifying and monetizing valuable investment opportunities in a dynamic market. Insights...

Continue Reading
CW Bancorp Announces Quarterly Dividend for Shareholders

Updated Category News Views 215

CW Bancorp Declares a Refreshing Quarterly Dividend CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, recently announced the approval of a quarterly cash dividend by its Board of Directors. This step signifies the company's ongoing dedication to maximizing shareholder value. The Board declared a cash dividend of $0.23 per common share, illustrating the...

Continue Reading
Investors Stand to Gain from Novo Nordisk A/S Class Action Suit

Updated Category News Views 188

Understanding the Opportunity in Novo Nordisk Class Action The recent developments surrounding Novo Nordisk A/S (NYSE: NVO) present a significant opportunity for investors to lead a class action lawsuit against the company. This initiative arises from allegations of securities fraud that may have impacted stockholder interests. The law firm managing this case assures that...

Continue Reading